LEXINGTON, Mass. (USA), and HEIDELBERG, Germany, Jan. 13, 2009 – febit holding GmbH, a developer of the flexible and automated biochip-based DNA-analysis platform Geniom®, today announced the appointment of Heinz Blunier, to the newly created position of Chief Operation Officer. Blunier previously served as Head of Engineering Department at Inventa, CEO of Tegimenta AG, a […]
Agilent Technologies Inc. (NYSE:A), today announced the release of eArray 5.4 online microarray design tool, which enables users to design custom microRNA (miRNA) microarrays. miRNA is a rapidly emerging field of study because researchers are increasingly associating these abundant molecules with some types of cancers, heart disease, other disorders and stem-cell differentiation. Researchers can use […]
Illumina, Inc. (NASDAQ:ILMN) today launched the Infinium® HD (High Density) iSelect Custom Genotyping solution. Researchers now have the flexibility to screen SNPs ranging from 3,000 to 200,000 in focused genotyping studies for both human and non-human species. This higher-density iSelect Custom Genotyping technology is the most versatile solution of its kind in the industry. It […]
Madison, 09.01.2009, Roche NimbleGen and Biogemma entered into a research agreement which will apply Roche NimbleGen’s array-based Sequence Capture complexity reduction technology to provide targeted re-sequencing of crop plant genomes. The goal of this partnership is to develop new technologies that enable large-scale genomic marker discovery in plants, which will greatly facilitate marker-assisted breeding programs […]
Leiden/San Diego, January 7, 2009 – ServiceXS announced today that it has successfully completed Illumina CSPro™ certification for Infinium® Genotyping, gaining entry to an elite group of Illumina genomics service providers globally. Illumina Inc., a San Diego-based company, provides leading-edge genetic analysis tools to genomics centers worldwide. Illumina CSPro is the collaborative service provider partnership […]
SeraCare Life Sciences, Inc. (NASDAQ: SRLS) and RayBiotech, Inc. announced today that SeraCare will act as an agent for the sale of RayBiotech’s full product line of antibody arrays, protein arrays, tissue microarrays and ELISA and EIA kits. The synergy of RayBiotech’s innovative portfolio with SeraCare’s global reach and expertise in virology, serology, immunology and […]
SANTA CLARA, Calif.–Affymetrix, Inc. (Nasdaq:AFFX – News) today announced that its technology was used by the Cincinnati Children’s Hospital Medical Center to develop an innovative molecular diagnostic test designed to help diagnose the genetic defects in patients with inheritable forms of jaundice. Jaundice is the most common symptom of liver disease in young children. Cincinnati […]
IGR Is Also European Reference Training Center SANTA CLARA, Calif. & VILLEJUIF, France–Agilent Technologies Inc. (NYSE:A) today announced that the Institut de cancérologie Gustave Roussy (IGR) Genomic Center has renewed its status as an Agilent Certified Service Provider and Reference Training Center for a broad panel of microarray technologies including comparative genomic hybridization (CGH), one-color […]
SANTA CLARA, Calif. & VILLEJUIF, France–Agilent Technologies Inc. (NYSE:A – News) today announced that the Institut de cancérologie Gustave Roussy (IGR) Genomic Center has renewed its status as an Agilent Certified Service Provider and Reference Training Center for a broad panel of microarray technologies including comparative genomic hybridization (CGH), one-color and dual-color gene expression, and […]
Affymetrix Inc., (Nasdaq:AFFX) announced today that scientists at Cancer Research UK have used Affymetrix technology to discover the molecular basis for tamoxifen response in breast cancer cells – and the reason why some women can develop resistance to the treatment. Their findings are published in Nature1. Tamoxifen is given to most women for five years […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
